| Carcinoma of Unknown Primary investigated in trials for …INVESTIGATED_IN_TRIALSderived200 of 325show all (up to 200) |
|---|
| → investigated in trials for | Pembrolizumabmonoclonal antibody 347 trials (161 active) · roll-up of the cancer and its descendants | — | — | Carcinoma of Unknown Primary | 347 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Cisplatinsmall molecule 270 trials (98 active) · roll-up of the cancer and its descendants | — | — | Carcinoma of Unknown Primary | 270 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Bevacizumabmonoclonal antibody 221 trials (90 active) · roll-up of the cancer and its descendants | — | — | Carcinoma of Unknown Primary | 221 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Nivolumabmonoclonal antibody 218 trials (89 active) · roll-up of the cancer and its descendants | — | — | Carcinoma of Unknown Primary | 218 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Carboplatinsmall molecule 195 trials (85 active) · roll-up of the cancer and its descendants | — | — | Carcinoma of Unknown Primary | 195 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Sorafenibsmall molecule 189 trials (14 active) · roll-up of the cancer and its descendants | — | — | Carcinoma of Unknown Primary | 189 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Paclitaxelsmall molecule 184 trials (69 active) · roll-up of the cancer and its descendants | — | — | Carcinoma of Unknown Primary | 184 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Gemcitabinesmall molecule 177 trials (48 active) · roll-up of the cancer and its descendants | — | — | Carcinoma of Unknown Primary | 177 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Fluorouracilsmall molecule 160 trials (41 active) · roll-up of the cancer and its descendants | — | — | Carcinoma of Unknown Primary | 160 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Lenvatinibsmall molecule 152 trials (66 active) · roll-up of the cancer and its descendants | — | — | Carcinoma of Unknown Primary | 152 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Cetuximabmonoclonal antibody 114 trials (28 active) · roll-up of the cancer and its descendants | — | — | Carcinoma of Unknown Primary | 114 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Docetaxelsmall molecule 114 trials (33 active) · roll-up of the cancer and its descendants | — | — | Carcinoma of Unknown Primary | 114 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Durvalumabmonoclonal antibody 108 trials (54 active) · roll-up of the cancer and its descendants | — | — | Carcinoma of Unknown Primary | 108 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Nab-paclitaxel 107 trials (39 active) · roll-up of the cancer and its descendants | — | — | Carcinoma of Unknown Primary | 107 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Atezolizumabmonoclonal antibody 102 trials (60 active) · roll-up of the cancer and its descendants | — | — | Carcinoma of Unknown Primary | 102 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Oxaliplatinsmall molecule 100 trials (27 active) · roll-up of the cancer and its descendants | — | — | Carcinoma of Unknown Primary | 100 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Cyclophosphamidesmall molecule 89 trials (33 active) · roll-up of the cancer and its descendants | — | — | Carcinoma of Unknown Primary | 89 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Ipilimumabmonoclonal antibody 88 trials (48 active) · roll-up of the cancer and its descendants | — | — | Carcinoma of Unknown Primary | 88 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Cabozantinibsmall molecule 87 trials (47 active) · roll-up of the cancer and its descendants | — | — | Carcinoma of Unknown Primary | 87 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Capecitabinesmall molecule 83 trials (27 active) · roll-up of the cancer and its descendants | — | — | Carcinoma of Unknown Primary | 83 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Everolimussmall molecule 75 trials (14 active) · roll-up of the cancer and its descendants | — | — | Carcinoma of Unknown Primary | 75 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Leucovorinsmall molecule 74 trials (17 active) · roll-up of the cancer and its descendants | — | — | Carcinoma of Unknown Primary | 74 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Irinotecansmall molecule 68 trials (19 active) · roll-up of the cancer and its descendants | — | — | Carcinoma of Unknown Primary | 68 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Sintilimabmonoclonal antibody 67 trials (32 active) · roll-up of the cancer and its descendants | — | — | Carcinoma of Unknown Primary | 67 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Tislelizumabmonoclonal antibody 62 trials (34 active) · roll-up of the cancer and its descendants | — | — | Carcinoma of Unknown Primary | 62 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Doxorubicinsmall molecule 57 trials (17 active) · roll-up of the cancer and its descendants | — | — | Carcinoma of Unknown Primary | 57 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Tremelimumabmonoclonal antibody 51 trials (27 active) · roll-up of the cancer and its descendants | — | — | Carcinoma of Unknown Primary | 51 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Toripalimabmonoclonal antibody 49 trials (23 active) · roll-up of the cancer and its descendants | — | — | Carcinoma of Unknown Primary | 49 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Sunitinibsmall molecule 48 trials (6 active) · roll-up of the cancer and its descendants | — | — | Carcinoma of Unknown Primary | 48 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Camrelizumabmonoclonal antibody 44 trials (17 active) · roll-up of the cancer and its descendants | — | — | Carcinoma of Unknown Primary | 44 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Olaparibsmall molecule 44 trials (26 active) · roll-up of the cancer and its descendants | — | — | Carcinoma of Unknown Primary | 44 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Fludarabinesmall molecule 38 trials (18 active) · roll-up of the cancer and its descendants | — | — | Carcinoma of Unknown Primary | 38 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Prednisonesmall molecule 38 trials (16 active) · roll-up of the cancer and its descendants | — | — | Carcinoma of Unknown Primary | 38 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Erlotinib Hydrochloridesmall molecule 34 trials (2 active) · roll-up of the cancer and its descendants | — | — | Carcinoma of Unknown Primary | 34 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Axitinibsmall molecule 33 trials (13 active) · roll-up of the cancer and its descendants | — | — | Carcinoma of Unknown Primary | 33 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Trastuzumabmonoclonal antibody 33 trials (11 active) · roll-up of the cancer and its descendants | — | — | Carcinoma of Unknown Primary | 33 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Enzalutamidesmall molecule 32 trials (10 active) · roll-up of the cancer and its descendants | — | — | Carcinoma of Unknown Primary | 32 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Regorafenibsmall molecule 32 trials (11 active) · roll-up of the cancer and its descendants | — | — | Carcinoma of Unknown Primary | 32 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Sorafenib Tosylatesmall molecule 32 trials (0 active) · roll-up of the cancer and its descendants | — | — | Carcinoma of Unknown Primary | 32 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Avelumabmonoclonal antibody 31 trials (9 active) · roll-up of the cancer and its descendants | — | — | Carcinoma of Unknown Primary | 31 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Leuprolideother 31 trials (14 active) · roll-up of the cancer and its descendants | — | — | Carcinoma of Unknown Primary | 31 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Pemetrexedsmall molecule 31 trials (7 active) · roll-up of the cancer and its descendants | — | — | Carcinoma of Unknown Primary | 31 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Cemiplimabmonoclonal antibody 27 trials (19 active) · roll-up of the cancer and its descendants | — | — | Carcinoma of Unknown Primary | 27 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Etoposidesmall molecule 27 trials (11 active) · roll-up of the cancer and its descendants | — | — | Carcinoma of Unknown Primary | 27 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Goserelinother 27 trials (13 active) · roll-up of the cancer and its descendants | — | — | Carcinoma of Unknown Primary | 27 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Lutetium (177lu) Oxodotreotideother 27 trials (14 active) · roll-up of the cancer and its descendants | — | — | Carcinoma of Unknown Primary | 27 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Chemotherapy 26 trials (13 active) · roll-up of the cancer and its descendants | — | — | Carcinoma of Unknown Primary | 26 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Erlotinibsmall molecule 26 trials (1 active) · roll-up of the cancer and its descendants | — | — | Carcinoma of Unknown Primary | 26 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Bicalutamidesmall molecule 23 trials (7 active) · roll-up of the cancer and its descendants | — | — | Carcinoma of Unknown Primary | 23 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Abemaciclibsmall molecule 22 trials (11 active) · roll-up of the cancer and its descendants | — | — | Carcinoma of Unknown Primary | 22 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Metforminsmall molecule 22 trials (4 active) · roll-up of the cancer and its descendants | — | — | Carcinoma of Unknown Primary | 22 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Pazopanibsmall molecule 22 trials (3 active) · roll-up of the cancer and its descendants | — | — | Carcinoma of Unknown Primary | 22 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Temozolomidesmall molecule 22 trials (4 active) · roll-up of the cancer and its descendants | — | — | Carcinoma of Unknown Primary | 22 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Abiraterone Acetatesmall molecule 21 trials (11 active) · roll-up of the cancer and its descendants | — | — | Carcinoma of Unknown Primary | 21 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Topotecansmall molecule 21 trials (6 active) · roll-up of the cancer and its descendants | — | — | Carcinoma of Unknown Primary | 21 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Aldesleukinother 19 trials (8 active) · roll-up of the cancer and its descendants | — | — | Carcinoma of Unknown Primary | 19 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Temsirolimussmall molecule 19 trials (0 active) · roll-up of the cancer and its descendants | — | — | Carcinoma of Unknown Primary | 19 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Apalutamidesmall molecule 18 trials (11 active) · roll-up of the cancer and its descendants | — | — | Carcinoma of Unknown Primary | 18 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Palbociclibsmall molecule 18 trials (7 active) · roll-up of the cancer and its descendants | — | — | Carcinoma of Unknown Primary | 18 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Cediranibsmall molecule 16 trials (9 active) · roll-up of the cancer and its descendants | — | — | Carcinoma of Unknown Primary | 16 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Letrozolesmall molecule 16 trials (9 active) · roll-up of the cancer and its descendants | — | — | Carcinoma of Unknown Primary | 16 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Veliparibsmall molecule 16 trials (3 active) · roll-up of the cancer and its descendants | — | — | Carcinoma of Unknown Primary | 16 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Filgrastimother 15 trials (1 active) · roll-up of the cancer and its descendants | — | — | Carcinoma of Unknown Primary | 15 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Gefitinibsmall molecule 15 trials (1 active) · roll-up of the cancer and its descendants | — | — | Carcinoma of Unknown Primary | 15 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Ramucirumabmonoclonal antibody 15 trials (4 active) · roll-up of the cancer and its descendants | — | — | Carcinoma of Unknown Primary | 15 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Bortezomibsmall molecule 14 trials (0 active) · roll-up of the cancer and its descendants | — | — | Carcinoma of Unknown Primary | 14 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Dexamethasonesmall molecule 14 trials (1 active) · roll-up of the cancer and its descendants | — | — | Carcinoma of Unknown Primary | 14 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Epirubicinsmall molecule 14 trials (0 active) · roll-up of the cancer and its descendants | — | — | Carcinoma of Unknown Primary | 14 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Fulvestrantsmall molecule 14 trials (8 active) · roll-up of the cancer and its descendants | — | — | Carcinoma of Unknown Primary | 14 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Tamoxifensmall molecule 14 trials (5 active) · roll-up of the cancer and its descendants | — | — | Carcinoma of Unknown Primary | 14 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Afatinibsmall molecule 13 trials (3 active) · roll-up of the cancer and its descendants | — | — | Carcinoma of Unknown Primary | 13 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Dasatinibsmall molecule 13 trials (1 active) · roll-up of the cancer and its descendants | — | — | Carcinoma of Unknown Primary | 13 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Degarelixother 13 trials (9 active) · roll-up of the cancer and its descendants | — | — | Carcinoma of Unknown Primary | 13 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Niraparibsmall molecule 13 trials (5 active) · roll-up of the cancer and its descendants | — | — | Carcinoma of Unknown Primary | 13 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Thalidomidesmall molecule 13 trials (1 active) · roll-up of the cancer and its descendants | — | — | Carcinoma of Unknown Primary | 13 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Trametinibsmall molecule 13 trials (3 active) · roll-up of the cancer and its descendants | — | — | Carcinoma of Unknown Primary | 13 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Vandetanibsmall molecule 13 trials (1 active) · roll-up of the cancer and its descendants | — | — | Carcinoma of Unknown Primary | 13 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Vorinostatsmall molecule 13 trials (2 active) · roll-up of the cancer and its descendants | — | — | Carcinoma of Unknown Primary | 13 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Panitumumabmonoclonal antibody 12 trials (5 active) · roll-up of the cancer and its descendants | — | — | Carcinoma of Unknown Primary | 12 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Pertuzumabmonoclonal antibody 12 trials (1 active) · roll-up of the cancer and its descendants | — | — | Carcinoma of Unknown Primary | 12 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Adebrelimabmonoclonal antibody 11 trials (8 active) · roll-up of the cancer and its descendants | — | — | Carcinoma of Unknown Primary | 11 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Eribulinsmall molecule 11 trials (4 active) · roll-up of the cancer and its descendants | — | — | Carcinoma of Unknown Primary | 11 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Nimotuzumabmonoclonal antibody 11 trials (3 active) · roll-up of the cancer and its descendants | — | — | Carcinoma of Unknown Primary | 11 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Retifanlimabmonoclonal antibody 11 trials (2 active) · roll-up of the cancer and its descendants | — | — | Carcinoma of Unknown Primary | 11 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Ribociclibsmall molecule 11 trials (4 active) · roll-up of the cancer and its descendants | — | — | Carcinoma of Unknown Primary | 11 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Ruxolitinibsmall molecule 11 trials (4 active) · roll-up of the cancer and its descendants | — | — | Carcinoma of Unknown Primary | 11 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Sirolimussmall molecule 11 trials (1 active) · roll-up of the cancer and its descendants | — | — | Carcinoma of Unknown Primary | 11 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Abirateronesmall molecule 10 trials (4 active) · roll-up of the cancer and its descendants | — | — | Carcinoma of Unknown Primary | 10 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Cabazitaxelsmall molecule 10 trials (5 active) · roll-up of the cancer and its descendants | — | — | Carcinoma of Unknown Primary | 10 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Cixutumumabmonoclonal antibody 10 trials (0 active) · roll-up of the cancer and its descendants | — | — | Carcinoma of Unknown Primary | 10 | Observed | clinicaltrials | graph → |
| → investigated in trials for | FOLFOX Regimen 10 trials (4 active) · roll-up of the cancer and its descendants | — | — | Carcinoma of Unknown Primary | 10 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Lapatinibsmall molecule 10 trials (0 active) · roll-up of the cancer and its descendants | — | — | Carcinoma of Unknown Primary | 10 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Pasireotideother 10 trials (0 active) · roll-up of the cancer and its descendants | — | — | Carcinoma of Unknown Primary | 10 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Belzutifansmall molecule 9 trials (8 active) · roll-up of the cancer and its descendants | — | — | Carcinoma of Unknown Primary | 9 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Hydroxychloroquinesmall molecule 9 trials (2 active) · roll-up of the cancer and its descendants | — | — | Carcinoma of Unknown Primary | 9 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Mitomycinsmall molecule 9 trials (1 active) · roll-up of the cancer and its descendants | — | — | Carcinoma of Unknown Primary | 9 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Pegargiminaseother 9 trials (1 active) · roll-up of the cancer and its descendants | — | — | Carcinoma of Unknown Primary | 9 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Pegfilgrastimother 9 trials (2 active) · roll-up of the cancer and its descendants | — | — | Carcinoma of Unknown Primary | 9 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Selumetinibsmall molecule 9 trials (0 active) · roll-up of the cancer and its descendants | — | — | Carcinoma of Unknown Primary | 9 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Akt Inhibitor MK2206 8 trials (0 active) · roll-up of the cancer and its descendants | — | — | Carcinoma of Unknown Primary | 8 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Cobimetinibsmall molecule 8 trials (4 active) · roll-up of the cancer and its descendants | — | — | Carcinoma of Unknown Primary | 8 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Copanlisibsmall molecule 8 trials (1 active) · roll-up of the cancer and its descendants | — | — | Carcinoma of Unknown Primary | 8 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Flutamidesmall molecule 8 trials (4 active) · roll-up of the cancer and its descendants | — | — | Carcinoma of Unknown Primary | 8 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Lenalidomidesmall molecule 8 trials (1 active) · roll-up of the cancer and its descendants | — | — | Carcinoma of Unknown Primary | 8 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Talazoparibsmall molecule 8 trials (2 active) · roll-up of the cancer and its descendants | — | — | Carcinoma of Unknown Primary | 8 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Alisertibsmall molecule 7 trials (0 active) · roll-up of the cancer and its descendants | — | — | Carcinoma of Unknown Primary | 7 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Alpelisibsmall molecule 7 trials (1 active) · roll-up of the cancer and its descendants | — | — | Carcinoma of Unknown Primary | 7 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Anastrozolesmall molecule 7 trials (5 active) · roll-up of the cancer and its descendants | — | — | Carcinoma of Unknown Primary | 7 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Binimetinibsmall molecule 7 trials (1 active) · roll-up of the cancer and its descendants | — | — | Carcinoma of Unknown Primary | 7 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Exemestanesmall molecule 7 trials (5 active) · roll-up of the cancer and its descendants | — | — | Carcinoma of Unknown Primary | 7 | Observed | clinicaltrials | graph → |
| → investigated in trials for | FOLFOX-4 Regimen 7 trials (1 active) · roll-up of the cancer and its descendants | — | — | Carcinoma of Unknown Primary | 7 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Methotrexatesmall molecule 7 trials (1 active) · roll-up of the cancer and its descendants | — | — | Carcinoma of Unknown Primary | 7 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Nintedanibsmall molecule 7 trials (0 active) · roll-up of the cancer and its descendants | — | — | Carcinoma of Unknown Primary | 7 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Relugolixsmall molecule 7 trials (7 active) · roll-up of the cancer and its descendants | — | — | Carcinoma of Unknown Primary | 7 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Romidepsinother 7 trials (0 active) · roll-up of the cancer and its descendants | — | — | Carcinoma of Unknown Primary | 7 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Sacituzumab Govitecanadc 7 trials (5 active) · roll-up of the cancer and its descendants | — | — | Carcinoma of Unknown Primary | 7 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Selpercatinibsmall molecule 7 trials (6 active) · roll-up of the cancer and its descendants | — | — | Carcinoma of Unknown Primary | 7 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Serplulimabmonoclonal antibody 7 trials (3 active) · roll-up of the cancer and its descendants | — | — | Carcinoma of Unknown Primary | 7 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Tegafursmall molecule 7 trials (0 active) · roll-up of the cancer and its descendants | — | — | Carcinoma of Unknown Primary | 7 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Adavosertibsmall molecule 6 trials (3 active) · roll-up of the cancer and its descendants | — | — | Carcinoma of Unknown Primary | 6 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Belinostatsmall molecule 6 trials (1 active) · roll-up of the cancer and its descendants | — | — | Carcinoma of Unknown Primary | 6 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Capivasertibsmall molecule 6 trials (4 active) · roll-up of the cancer and its descendants | — | — | Carcinoma of Unknown Primary | 6 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Decitabinesmall molecule 6 trials (2 active) · roll-up of the cancer and its descendants | — | — | Carcinoma of Unknown Primary | 6 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Dostarlimabmonoclonal antibody 6 trials (5 active) · roll-up of the cancer and its descendants | — | — | Carcinoma of Unknown Primary | 6 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Ganitumabmonoclonal antibody 6 trials (0 active) · roll-up of the cancer and its descendants | — | — | Carcinoma of Unknown Primary | 6 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Hydroxyureasmall molecule 6 trials (1 active) · roll-up of the cancer and its descendants | — | — | Carcinoma of Unknown Primary | 6 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Immune Checkpoint Inhibitor 6 trials (3 active) · roll-up of the cancer and its descendants | — | — | Carcinoma of Unknown Primary | 6 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Lurbinectedinsmall molecule 6 trials (4 active) · roll-up of the cancer and its descendants | — | — | Carcinoma of Unknown Primary | 6 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Neratinibsmall molecule 6 trials (2 active) · roll-up of the cancer and its descendants | — | — | Carcinoma of Unknown Primary | 6 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Osimertinibsmall molecule 6 trials (1 active) · roll-up of the cancer and its descendants | — | — | Carcinoma of Unknown Primary | 6 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Sapanisertibsmall molecule 6 trials (2 active) · roll-up of the cancer and its descendants | — | — | Carcinoma of Unknown Primary | 6 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Tipifarnibsmall molecule 6 trials (0 active) · roll-up of the cancer and its descendants | — | — | Carcinoma of Unknown Primary | 6 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Tivozanibsmall molecule 6 trials (3 active) · roll-up of the cancer and its descendants | — | — | Carcinoma of Unknown Primary | 6 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Triptorelinother 6 trials (3 active) · roll-up of the cancer and its descendants | — | — | Carcinoma of Unknown Primary | 6 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Zoledronic Acidsmall molecule 6 trials (1 active) · roll-up of the cancer and its descendants | — | — | Carcinoma of Unknown Primary | 6 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Afliberceptother 5 trials (0 active) · roll-up of the cancer and its descendants | — | — | Carcinoma of Unknown Primary | 5 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Anti-PD1 Monoclonal Antibody 5 trials (2 active) · roll-up of the cancer and its descendants | — | — | Carcinoma of Unknown Primary | 5 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Berzosertibsmall molecule 5 trials (5 active) · roll-up of the cancer and its descendants | — | — | Carcinoma of Unknown Primary | 5 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Celecoxibsmall molecule 5 trials (1 active) · roll-up of the cancer and its descendants | — | — | Carcinoma of Unknown Primary | 5 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Dabrafenibsmall molecule 5 trials (2 active) · roll-up of the cancer and its descendants | — | — | Carcinoma of Unknown Primary | 5 | Observed | clinicaltrials | graph → |
| → investigated in trials for | FOLFIRI Regimen 5 trials (1 active) · roll-up of the cancer and its descendants | — | — | Carcinoma of Unknown Primary | 5 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Ganetespibsmall molecule 5 trials (0 active) · roll-up of the cancer and its descendants | — | — | Carcinoma of Unknown Primary | 5 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Hormone Therapy 5 trials (4 active) · roll-up of the cancer and its descendants | — | — | Carcinoma of Unknown Primary | 5 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Ipilimumab/Nivolumab Regimen 5 trials (3 active) · roll-up of the cancer and its descendants | — | — | Carcinoma of Unknown Primary | 5 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Lutetium (177lu) Vipivotide Tetraxetanother 5 trials (5 active) · roll-up of the cancer and its descendants | — | — | Carcinoma of Unknown Primary | 5 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Pralsetinibsmall molecule 5 trials (0 active) · roll-up of the cancer and its descendants | — | — | Carcinoma of Unknown Primary | 5 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Rucaparibsmall molecule 5 trials (1 active) · roll-up of the cancer and its descendants | — | — | Carcinoma of Unknown Primary | 5 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Tarlatamabmonoclonal antibody 5 trials (4 active) · roll-up of the cancer and its descendants | — | — | Carcinoma of Unknown Primary | 5 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Tazemetostatsmall molecule 5 trials (2 active) · roll-up of the cancer and its descendants | — | — | Carcinoma of Unknown Primary | 5 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Vismodegibsmall molecule 5 trials (1 active) · roll-up of the cancer and its descendants | — | — | Carcinoma of Unknown Primary | 5 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Alvocidibsmall molecule 4 trials (0 active) · roll-up of the cancer and its descendants | — | — | Carcinoma of Unknown Primary | 4 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Arsenic Trioxidesmall molecule 4 trials (0 active) · roll-up of the cancer and its descendants | — | — | Carcinoma of Unknown Primary | 4 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Buparlisibsmall molecule 4 trials (0 active) · roll-up of the cancer and its descendants | — | — | Carcinoma of Unknown Primary | 4 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Capmatinibsmall molecule 4 trials (0 active) · roll-up of the cancer and its descendants | — | — | Carcinoma of Unknown Primary | 4 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Crizotinibsmall molecule 4 trials (0 active) · roll-up of the cancer and its descendants | — | — | Carcinoma of Unknown Primary | 4 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Fruquintinibsmall molecule 4 trials (1 active) · roll-up of the cancer and its descendants | — | — | Carcinoma of Unknown Primary | 4 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Histrelinother 4 trials (2 active) · roll-up of the cancer and its descendants | — | — | Carcinoma of Unknown Primary | 4 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Icotinibsmall molecule 4 trials (0 active) · roll-up of the cancer and its descendants | — | — | Carcinoma of Unknown Primary | 4 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Imatinibsmall molecule 4 trials (0 active) · roll-up of the cancer and its descendants | — | — | Carcinoma of Unknown Primary | 4 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Immunotherapy 4 trials (2 active) · roll-up of the cancer and its descendants | — | — | Carcinoma of Unknown Primary | 4 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Ipatasertibsmall molecule 4 trials (4 active) · roll-up of the cancer and its descendants | — | — | Carcinoma of Unknown Primary | 4 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Melphalansmall molecule 4 trials (1 active) · roll-up of the cancer and its descendants | — | — | Carcinoma of Unknown Primary | 4 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Poziotinibsmall molecule 4 trials (0 active) · roll-up of the cancer and its descendants | — | — | Carcinoma of Unknown Primary | 4 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Selinexorsmall molecule 4 trials (1 active) · roll-up of the cancer and its descendants | — | — | Carcinoma of Unknown Primary | 4 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Sonidegibsmall molecule 4 trials (2 active) · roll-up of the cancer and its descendants | — | — | Carcinoma of Unknown Primary | 4 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Talimogene Laherparepvecgene therapy 4 trials (1 active) · roll-up of the cancer and its descendants | — | — | Carcinoma of Unknown Primary | 4 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Valproic Acidsmall molecule 4 trials (1 active) · roll-up of the cancer and its descendants | — | — | Carcinoma of Unknown Primary | 4 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Vemurafenibsmall molecule 4 trials (2 active) · roll-up of the cancer and its descendants | — | — | Carcinoma of Unknown Primary | 4 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Vincristinesmall molecule 4 trials (2 active) · roll-up of the cancer and its descendants | — | — | Carcinoma of Unknown Primary | 4 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Vinorelbinesmall molecule 4 trials (0 active) · roll-up of the cancer and its descendants | — | — | Carcinoma of Unknown Primary | 4 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Amivantamabmonoclonal antibody 3 trials (2 active) · roll-up of the cancer and its descendants | — | — | Carcinoma of Unknown Primary | 3 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Aspirinsmall molecule 3 trials (0 active) · roll-up of the cancer and its descendants | — | — | Carcinoma of Unknown Primary | 3 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Ceritinibsmall molecule 3 trials (0 active) · roll-up of the cancer and its descendants | — | — | Carcinoma of Unknown Primary | 3 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Daratumumabmonoclonal antibody 3 trials (0 active) · roll-up of the cancer and its descendants | — | — | Carcinoma of Unknown Primary | 3 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Darolutamidesmall molecule 3 trials (2 active) · roll-up of the cancer and its descendants | — | — | Carcinoma of Unknown Primary | 3 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Denosumabmonoclonal antibody 3 trials (1 active) · roll-up of the cancer and its descendants | — | — | Carcinoma of Unknown Primary | 3 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Disitamab Vedotinadc 3 trials (3 active) · roll-up of the cancer and its descendants | — | — | Carcinoma of Unknown Primary | 3 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Dovitinibsmall molecule 3 trials (0 active) · roll-up of the cancer and its descendants | — | — | Carcinoma of Unknown Primary | 3 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Elimusertibsmall molecule 3 trials (3 active) · roll-up of the cancer and its descendants | — | — | Carcinoma of Unknown Primary | 3 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Enfortumab Vedotinadc 3 trials (3 active) · roll-up of the cancer and its descendants | — | — | Carcinoma of Unknown Primary | 3 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Entrectinibsmall molecule 3 trials (1 active) · roll-up of the cancer and its descendants | — | — | Carcinoma of Unknown Primary | 3 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Estramustinesmall molecule 3 trials (0 active) · roll-up of the cancer and its descendants | — | — | Carcinoma of Unknown Primary | 3 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Firmonertinibsmall molecule 3 trials (1 active) · roll-up of the cancer and its descendants | — | — | Carcinoma of Unknown Primary | 3 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Guadecitabinesmall molecule 3 trials (2 active) · roll-up of the cancer and its descendants | — | — | Carcinoma of Unknown Primary | 3 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Idarubicinsmall molecule 3 trials (0 active) · roll-up of the cancer and its descendants | — | — | Carcinoma of Unknown Primary | 3 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Lifileucelcell therapy 3 trials (1 active) · roll-up of the cancer and its descendants | — | — | Carcinoma of Unknown Primary | 3 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Mitoxantronesmall molecule 3 trials (1 active) · roll-up of the cancer and its descendants | — | — | Carcinoma of Unknown Primary | 3 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Nilutamidesmall molecule 3 trials (2 active) · roll-up of the cancer and its descendants | — | — | Carcinoma of Unknown Primary | 3 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Panobinostatsmall molecule 3 trials (0 active) · roll-up of the cancer and its descendants | — | — | Carcinoma of Unknown Primary | 3 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Peginterferon Alfa-2bother 3 trials (1 active) · roll-up of the cancer and its descendants | — | — | Carcinoma of Unknown Primary | 3 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Ponatinibsmall molecule 3 trials (0 active) · roll-up of the cancer and its descendants | — | — | Carcinoma of Unknown Primary | 3 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Porfimer 3 trials (0 active) · roll-up of the cancer and its descendants | — | — | Carcinoma of Unknown Primary | 3 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Tanespimycinsmall molecule 3 trials (0 active) · roll-up of the cancer and its descendants | — | — | Carcinoma of Unknown Primary | 3 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Trastuzumab Emtansineadc 3 trials (0 active) · roll-up of the cancer and its descendants | — | — | Carcinoma of Unknown Primary | 3 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Tretinoinsmall molecule 3 trials (0 active) · roll-up of the cancer and its descendants | — | — | Carcinoma of Unknown Primary | 3 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Vatalanibsmall molecule 3 trials (0 active) · roll-up of the cancer and its descendants | — | — | Carcinoma of Unknown Primary | 3 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Zanidatamabmonoclonal antibody 3 trials (3 active) · roll-up of the cancer and its descendants | — | — | Carcinoma of Unknown Primary | 3 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Abexinostatsmall molecule 2 trials (0 active) · roll-up of the cancer and its descendants | — | — | Carcinoma of Unknown Primary | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Autologous peripheral-blood mononuclear cells activated with prostatic acid phosphatase granulocyte-macrophage colony-stimulating factor 2 trials (0 active) · roll-up of the cancer and its descendants | — | — | Carcinoma of Unknown Primary | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Avutometinib And Defactinib 2 trials (2 active) · roll-up of the cancer and its descendants | — | — | Carcinoma of Unknown Primary | 2 | Observed | clinicaltrials | graph → |